XML 28 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investment in associates and joint ventures
12 Months Ended
Dec. 31, 2017
Text block1 [abstract]  
Investment in associates and joint ventures

14. Investment in associates and joint ventures

 

     Associates
$m
     Joint
ventures
$m
     Total
$m
 

Cost

        

At 1 January 2016

     121        27        148  
  

 

 

    

 

 

    

 

 

 

Additions

     14        —          14  

Share of (losses)/profits

     (3      1        (2

Capital return

     —          (2      (2

Transfer of financial assets

     (14      —          (14

Dividends

     (5      —          (5
  

 

 

    

 

 

    

 

 

 

At 31 December 2016

     113        26        139  
  

 

 

    

 

 

    

 

 

 

Additions

     47        —          47  

Share of profits/(losses)

     2        1        3  

Disposals

     (9      —          (9

Dividends

     (4      —          (4

Exchange and other adjustments

     2        —          2  
  

 

 

    

 

 

    

 

 

 

At 31 December 2017

     151        27        178  
  

 

 

    

 

 

    

 

 

 

Impairment

        

At 1 January 2016

     (12      —          (12

Charge for the year

     (16      —          (16
  

 

 

    

 

 

    

 

 

 

At 31 December 2016

     (28      —          (28
  

 

 

    

 

 

    

 

 

 

Charge for the year

     (18      —          (18
  

 

 

    

 

 

    

 

 

 

Disposals

     9        —          9  
  

 

 

    

 

 

    

 

 

 

At 31 December 2017

     (37      —          (37
  

 

 

    

 

 

    

 

 

 

Net book value

        

At 31 December 2017

     114        27        141  
  

 

 

    

 

 

    

 

 

 

At 31 December 2016

     85        26        111  
  

 

 

    

 

 

    

 

 

 

At 1 January 2016

     109        27        136  
  

 

 

    

 

 

    

 

 

 

All associates and joint ventures are accounted for using the equity method.

During 2016, an investment for which the Group has a 30% interest was transferred to other financial assets following loss of significant influence over the operating and financial policy decisions of the entity.

The impairment charges of $18m and $16m in 2017 and 2016 respectively, relate to the Barclay associate (see following page) and result from the currently depressed trading outlook for the New York hotel market and the high costs of renovating the hotel. The recoverable amount of the investment has been measured at its fair value less costs of disposal, based on the Group’s share of the market value of the hotel less debt in the associate. The hotel was appraised by a professional external valuer using an income capitalisation approach which is a discounted cash flow technique that measures the present value of projected income flows (over a 10-year period) and the reversion of the property sale. Within the fair value hierarchy, this is categorised as a Level 3 fair value measurement. In addition to the projected income flows, the key assumptions used were a discount rate of 7.3% (2016: 7.3%) and a terminal capitalisation rate of 6.3% (2016: 6.0%).

Due to localised adverse market conditions, an impairment charge of $9m was recognised during 2015 relating to an associate investment in the AMEA region following a re-assessment of its recoverable amount to $nil, based on value in use calculations. Estimated future cash flows were discounted at a pre-tax rate of 13.2%. During 2017, the investment was disposed of for $nil proceeds.

On 20 November 2015, the Group disposed of an associate investment in the AMEA region realising a gain on disposal of $9m. At the time of disposal, the investment had a $nil net book value.

Barclay associate

The Group held one material associate investment at 31 December 2017, a 19.9% interest in 111 East 48th Street Holdings, LLC (the Barclay associate) which owns InterContinental New York Barclay (the hotel), a hotel managed by the Group. The hotel reopened for trading in April 2016 following a major renovation. The investment is classified as an associate and equity accounted. Whilst the Group has the ability to exercise significant influence through certain decision rights, approval rights relating to the hotel’s operating and capital budgets rest solely with the 80.1% majority member. The Group’s ability to receive cash dividends is dependent on the hotel generating sufficient income to satisfy specified owner returns.

In March 2017, the Group invested $43m in the Barclay associate in conjunction with a refinancing of the hotel. The cash was used to repay a $43m supplemental bank loan for which the Group had previously provided an indemnity for 100% of the related obligations. As a consequence, the indemnity has been extinguished.

Summarised financial information in respect of the Barclay associate is set out below:

 

     31 December 2017
$m
     31 December 2016
$m
 

Non-current assets

     540        552  

Current assets

     41        19  

Current liabilities

     (19      (283

Non-current liabilities

     (287      (39
  

 

 

    

 

 

 

Net assets

     275        249  
  

 

 

    

 

 

 

Group share of reported net assets at 19.9%

     55        50  

Adjustments to reflect capitalised costs, and additional rights and obligations
under the shareholder agreement

     10        (7
  

 

 

    

 

 

 

Carrying amount

     65        43  
  

 

 

    

 

 

 
     12 months to
31 December 2017
$m
     12 months to
31 December 2016
$m
 

Revenue

     90        45  

Loss for the period

     (16      (34

Group’s share of loss for the period

     (4      (8

Other associates and joint ventures

The summarised aggregated financial information for individually immaterial associates and joint ventures is set out below. These are mainly investments in entities that own hotels which the Group manages.

 

     Associates      Joint ventures     Total  
     2017
$m
     2016
$m
     2015
$m
     2017
$m
     2016
$m
     2015
$m
    2017
$m
     2016
$m
     2015
$m
 

Share of profits/(losses)

                         

Operating profits/(losses)
before exceptional items

     6        5        3        1        1        (1     7        6        2